New combo therapy targets tough cancers
Disease control
Recruiting now
This study tests a new drug called BOLD-100 combined with standard chemotherapy (FOLFOX) in people with advanced colorectal, pancreatic, stomach, or bile duct cancers. The goal is to see if the combination is safe and can shrink tumors or slow cancer growth. About 220 adults whos…
Phase: PHASE1, PHASE2 • Sponsor: Bold Therapeutics, Inc. • Aim: Disease control
Last updated Jun 12, 2026 12:07 UTC